BiotechTube
Home/Cardurion Pharmaceuticals/Howard K. Surks, M.D.
HK

Howard K. Surks, M.D.

Chief Medical and Scientific Officer

Cardurion Pharmaceuticals

Therapeutic Areas

CardiovascularHeart FailureArrhythmias

Cardurion Pharmaceuticals Pipeline

DrugIndicationPhase
PDE9 InhibitorHeart Failure (HFrEF and HFpEF)Clinical
CaMKII InhibitorCatecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Heart Failure, Atrial FibrillationClinical

Leadership Team at Cardurion Pharmaceuticals

PS
Peter S. Lawrence, J.D.
President and CEO
ME
Michael E. Mendelsohn, M.D.
Founder and Chief Strategy Officer
ER
Elizabeth Radcliffe
Chief Financial Officer
CN
Charlotte Newman
Chief Business & Operations Officer
View full Cardurion Pharmaceuticals profile